Company / CapEx per Share
Sunshine Biopharma Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.64
FY2025
5-year range
$0.00 / $5.87
FY2021-FY2025
Trend
-89.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2022 to $5.87 in FY2024.
Based on SEC 10-K filings.
0.64 in FY2025 with a 5-year CAGR of +666.0%.
Improved from $0.01 to $0.64 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +666.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share decreased 89.1% year-over-year.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.64 | -89.1% |
| FY2024 | $5.87 | +68245.8% |
| FY2023 | $0.01 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.00 | +2724.0% |
| FY2020 | $0.00 | -99.4% |
| FY2019 | $0.00 | +5338.2% |
| FY2018 | $0.00 | +1710.8% |
| FY2017 | $0.00 | -81.5% |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026